Improving care for people with type 2 diabetes.
QBSafe: a randomized trial of a novel intervention to improve care for people living with type 2 diabetes.
['FUNDING_R01'] · YALE UNIVERSITY · NIH-10807960
This study is looking to improve the care of people with type 2 diabetes by focusing not just on blood sugar levels, but also on making sure you feel good and stay healthy overall, using a new program called QBSafe that helps you talk with your doctor about what matters most to you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10807960 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the care of individuals living with type 2 diabetes by shifting the focus from merely achieving glycemic control to a more holistic approach that considers the overall well-being of patients. The study will test a novel intervention called QBSafe, which emphasizes quality of life, treatment burden, safety, and prevention of future complications. Patients will be equipped with tools to facilitate discussions with their healthcare providers, ensuring that their individual circumstances and preferences are taken into account during treatment planning.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with type 2 diabetes who may be struggling with treatment adherence or experiencing negative impacts on their daily lives due to their condition.
Not a fit: Patients who do not have type 2 diabetes or those with well-controlled diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved quality of life and better management of type 2 diabetes for patients.
How similar studies have performed: Previous research has shown that patient-centered approaches in diabetes care can lead to better health outcomes, suggesting that this novel intervention may also be effective.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIPSKA, KASIA JOANNA — YALE UNIVERSITY
- Study coordinator: LIPSKA, KASIA JOANNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: diabetes, Diabetes Mellitus, Adult-Onset Diabetes Mellitus, Ketosis-Resistant Diabetes Mellitus, Maturity-Onset Diabetes Mellitus